HP&M’s Sara Koblitz to Present at DC Bar’s FDA for IP Lawyers Webinar

Hyman, Phelps, and McNamara’s Sara Koblitz will be presenting at the DC Bar’s annual webinar, “FDA for IP Lawyers” on May 25, 2022 with Brian Malkin of McDermott, Will, and Emery.

The webinar will provide practical tips for integrating FDA regulatory law into IP law practices for FDA-regulated products and hopes that this program will be the springboard for future more in-depth FDA legal topics relevant to IP lawyers.  The event has been revamped with new commentary on recent cases and legislative topics, including:

• GSK v. Teva and follow-up on skinny labeling
• FDA letter to USPTO / GW Roundtable  (patent listings, patent prosecution, patent thickets/evergreening, and more)
• Catalyst and orphan drug exclusivity
• 180-day exclusivity and potential BLOCKING Act
• Biologics transferred from NDAs to BLAs and impact
• Interchangeable biosimilars and impact going forward

For registration information, please see the DC Bar’s website here